An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors
A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA vaccine significantly increases the potency of therapeutic immune cells. The paper is published in the journal Cancer…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.